1. Build a Strong Employer BrandFirst up, let’s talk about your employer brand. Think of it as your company’s personality and reputation. In Japan’s competitive pharmaceutical and medical device industry, it’s crucial to stand out. You need to showcase your…
HOME > REGULATORY
REGULATORY
- New Rules for Application of GCP Ordinance to Take Effect April 1, 2012
October 25, 2011
- EMA Confirms Usefulness of Pioglitazone-Containing Medicines as 2nd, 3rd Line Treatment Options: Takeda
October 24, 2011
- Survey Finds Slight Increase in Generic Drug Dispensing Rate
October 24, 2011
- Korosho Receives 270 Requests for Development of Unapproved Drugs, Indications in 2nd Round
October 24, 2011
- Groups of Care Providers, Patients Against Creating Compensation System for Injury from Anticancer Drugs
October 22, 2011
- Drug Discovery Support Agency Will Not Compete with Private Sector: Mr Tsuchiya
October 21, 2011
- CSIMC Recommended Approval for Reimbursement on Piecework for 2 High-Priced Drugs
October 21, 2011
- Survey Finds Slight Increase in Generic Drug Dispensing Rate
October 21, 2011
- MHLW to Review Premium System Placing Priority on Premium for Pediatric Use
October 20, 2011
- Mr Kobayashi of Chuikyo Insists on NHI Price Reductions for New Generics
October 20, 2011
- MHLW Subcommittee Agrees on Access System for Domestically Unapproved Drugs
October 20, 2011
- MHLW Presents Data at Chuikyo Supporting Reduction in 70% Rule for New Generics
October 20, 2011
- Cost of Advanced Healthcare Services Totaled ¥13.2 Billion in FY2010: Korosho
October 20, 2011
- HSC Subcommittee Considering Review of Refractory Diseases Eligible for Treatment Subsidies
October 20, 2011
- MHLW Revises Precautions for Use in OTC Drugs
October 19, 2011
- PMDA Presents Warnings on Website to Prevent Mistaken Use of 3 Taxane Drugs
October 19, 2011
- Korosho Proposes 80% Price Rule for Single-enantiomer Drugs
October 19, 2011
- Korosho Presents Direction for PAL Amendment in 2012
October 19, 2011
- Council to Set Up Committee to Discuss Creation of “Drug Discovery Support Organization”
October 18, 2011
- MHLW to Survey, Consider Measures for Clinical Trials in Coping with Earthquakes
October 17, 2011
ページ
In late January, a bill to amend the Pharmaceuticals and Medical Devices Act cleared key legislation review processes by the…
A Japanese health ministry panel on December 26 wrapped up its discussions on the next amendment of the Pharmaceuticals and…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s key reimbursement policy panel on December 25 approved an outline of the FY2025 drug price revision, finalizing plans to…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
A Japanese health ministry panel discussing the generic industry structure on May 22 put together a report in which it…
A Japanese health ministry study group focused on pharmaceutical regulations on March 21 agreed on a policy to encourage the…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…